AUROBINDO PHARMA Limited - RESULTS FOR THE SECOND QUARTER ENDED SEP'2017 - Q2-FY 2017-18

 

AUROBINDO PHARMA

Limited

RESULTS FOR THE

SECOND QUARTER ENDED SEP'2017

Q2-FY 2017-18

The results of AUROBINDO PHARMA Limited for the second quarter ended Sep'2017 are placed here under.


Sales have gone up by 17.25% YoY. Net Profits have gone up by 29% YoY. At current price of Rs.708, PE (Forward) stands at 13.28. AUROBINDO has declared Interim Dividend of Rs.1.50 per share of FV of Rs.1.
  
Declaration : This does not constitute a Buy/Sell/Hold Recommendation.

AUROBINDO PHARMA	Sep '17	Jun '17	Mar '17	Dec '16	Sep '16	YOY
Net Sales	4,354.18	3,621.07	3,582.13	3,844.47	3,713.58	17.25
Other Operating Income	81.71	57.68	59.5	61.71	61.87	32.07
Total Income	4,435.89	3,678.75	3,641.63	3,906.18	3,775.45	17.49
EXPENDITURE
Raw Materials	1,439.54	1,378.33	1,279.42	1,300.59	1,374.85	4.71
Purchase of Traded Goods	355.91	340.41	347.69	443.62	358.29	-0.66
Increase in Stocks	-27.52	-220.91	-124.3	-34.5	-103.26	-73.35
Employees Cost	518.72	490.17	463.46	445.64	426.58	21.6
Depreciation	132.08	131.18	100.05	111.14	110.2	19.85
Other Expenses	1,032.36	867.98	954.12	855.99	789.78	30.71
P/L Before Other Inc., Int., Excpt. Items & Tax	984.8	691.59	621.19	783.7	819.01	20.24
Other Income	10.27	33.26	40.78	7.92	8.28	24.03
P/L Before Int., Excpt. Items & Tax	995.07	724.85	661.97	791.62	827.29	20.28
Interest	17.27	16.87	14.28	-1.54	-2.65	-751.7
P/L Before Tax	977.8	707.98	647.69	793.16	829.94	17.82
Tax	197.96	190.99	117.15	217.67	223.99	-11.62
Net Profit	779.84	516.99	530.54	575.49	605.95	28.7
Minority Interest	0.18	0.18	0.23	0.09	0.09	100
Share Of P/L Of Associates	1.13	1.34	1.68	3.01	-0.4	-382.5
Net P/L After M.I & Associates	781.15	518.51	532.45	578.59	605.64	28.98
Equity	58.59	58.59	58.59	58.52	58.52	0.12
Basic EPS	13.33	8.85	9.1	9.88	10.41	28.05
Diluted EPS	13.33	8.85	9.1	9.88	10.4	28.17
MP	708
PE	13.28